BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16709859)

  • 1. STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.
    Rothfuchs AG; Trumstedt C; Mattei F; Schiavoni G; Hidmark A; Wigzell H; Rottenberg ME
    J Immunol; 2006 Jun; 176(11):6982-90. PubMed ID: 16709859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.
    Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME
    J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
    Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
    J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae.
    Rottenberg ME; Gigliotti Rothfuchs A; Gigliotti D; Ceausu M; Une C; Levitsky V; Wigzell H
    J Immunol; 2000 May; 164(9):4812-8. PubMed ID: 10779789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance.
    Yang T; Stark P; Janik K; Wigzell H; Rottenberg ME
    J Immunol; 2008 Mar; 180(6):4040-9. PubMed ID: 18322213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection.
    Rothfuchs AG; Gigliotti D; Palmblad K; Andersson U; Wigzell H; Rottenberg ME
    J Immunol; 2001 Dec; 167(11):6453-61. PubMed ID: 11714812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for innate IFNs in determining respiratory syncytial virus immunopathology.
    Johnson TR; Mertz SE; Gitiban N; Hammond S; Legallo R; Durbin RK; Durbin JE
    J Immunol; 2005 Jun; 174(11):7234-41. PubMed ID: 15905569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.
    Rottenberg ME; Gigliotti Rothfuchs AC; Gigliotti D; Svanholm C; Bandholtz L; Wigzell H
    J Immunol; 1999 Mar; 162(5):2829-36. PubMed ID: 10072530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways.
    Malmgaard L; Salazar-Mather TP; Lewis CA; Biron CA
    J Virol; 2002 May; 76(9):4520-5. PubMed ID: 11932417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective DNA immunization against Chlamydia pneumoniae.
    Svanholm C; Bandholtz L; Castaños-Velez E; Wigzell H; Rottenberg ME
    Scand J Immunol; 2000 Apr; 51(4):345-53. PubMed ID: 10736106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of gamma interferon receptor expression due to Chlamydia-toll-like receptor interaction does not enhance signal transducer and activator of transcription 1 signaling.
    Shirey KA; Jung JY; Carlin JM
    Infect Immun; 2006 Dec; 74(12):6877-84. PubMed ID: 17030574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
    Yap GS; Sher A
    J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of STAT1 in Chlamydia-Induced Type-1 Interferon Production in Oviduct Epithelial Cells.
    Hosey KL; Hu S; Derbigny WA
    J Interferon Cytokine Res; 2015 Nov; 35(11):901-16. PubMed ID: 26262558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.
    Leib DA; Harrison TE; Laslo KM; Machalek MA; Moorman NJ; Virgin HW
    J Exp Med; 1999 Feb; 189(4):663-72. PubMed ID: 9989981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection.
    Geng Y; Berencsi K; Gyulai Z; Valyi-Nagy T; Gonczol E; Trinchieri G
    Infect Immun; 2000 Apr; 68(4):2245-53. PubMed ID: 10722626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.
    Kuchtey J; Fulton SA; Reba SM; Harding CV; Boom WH
    Immunology; 2006 May; 118(1):39-49. PubMed ID: 16630021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria.
    Mancuso G; Midiri A; Biondo C; Beninati C; Zummo S; Galbo R; Tomasello F; Gambuzza M; Macrì G; Ruggeri A; Leanderson T; Teti G
    J Immunol; 2007 Mar; 178(5):3126-33. PubMed ID: 17312160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
    Shi S; Blumenthal A; Hickey CM; Gandotra S; Levy D; Ehrt S
    J Immunol; 2005 Sep; 175(5):3318-28. PubMed ID: 16116224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyD88 and interferon-alpha/beta are differentially required for dendritic cell maturation but dispensable for development of protective memory against Listeria.
    Tam MA; Wick MJ
    Immunology; 2009 Nov; 128(3):429-38. PubMed ID: 20067542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.
    Wizel B; Starcher BC; Samten B; Chroneos Z; Barnes PF; Dzuris J; Higashimoto Y; Appella E; Sette A
    J Immunol; 2002 Sep; 169(5):2524-35. PubMed ID: 12193722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.